Custom CRISPR/Cas9-based knockout of multiple genes in Pseudomonas putida with verified mutant deliverables.
Targeted deletion of multiple genes in GRAS-class Pseudomonas putida for metabolic engineering and pathway analysis.
We offer a streamlined pipeline for multi-gene knockout using optimized CRISPR vectors and screening protocols.
Simultaneous or sequential knockout of multiple genes with minimal off-target effects and flexible marker selection.
Every final strain is confirmed by PCR, Sanger sequencing, and phenotypic assessment when applicable.
Deep experience with Pseudomonas putida genetics and transformation, ensuring high editing efficiency.
Targeted gene knockouts for pathway optimization, metabolite production, and stress tolerance improvement.
Projects range from single-gene knockouts to multi-locus deletions for strain development programs.
Every project concludes with validated strains and comprehensive documentation.
Each project is scoped case-by-case after consultation to match your experimental goals.
| Parameter | Typical project scope |
|---|---|
| Host Strain | Customer-provided strain or lab stock (e.g., KT2440, DOT-T1E); subject to compatibility check |
| Number of Knockout Targets | Typically 2–5 genes per project; higher multiplexing evaluated on request |
| Editing Modality | Full gene knockout, large-fragment deletion, or site-directed disruption via CRISPR/Cas9 |
| Selection Strategy | Antibiotic resistance marker or markerless (counter-selection) as agreed in project plan |
| Validation | PCR + Sanger sequencing of each edited locus; optional off-target amplicon sequencing |
| Replicates | At least 2 independent clones confirmed per target to support genotypic consistency |
A five-step process from design to delivery of verified multi-gene knockout strains.
We discuss your target genes, host strain, and desired editing strategy. Our bioinformatics team designs sgRNAs and selects the optimal CRISPR vector for your application.
Each sgRNA cassette is synthesized and cloned into a Cas9-bearing plasmid optimized for Pseudomonas putida. Multiple vectors are prepared.
The CRISPR construct is introduced into P. putida via electroporation or conjugation. Transformants are selected on appropriate antibiotics and verified by colony PCR.
Individual colonies are screened for the desired deletion(s) using target-specific PCR. Positive clones are subjected to Sanger sequencing to confirm clean knockout junctions.
Confirmed mutants are streaked for purity, glycerol stocked, and subjected to final QC (plasmid loss confirmation if applicable). A comprehensive data package and the strain(s) are shipped.
Multi-gene knockout strains enable diverse studies in Pseudomonas putida.
Eliminate competing pathways or introduce catabolic bottlenecks to redirect carbon flux toward target products.
Knockout regulatory or redundant genes to boost the strain's ability to degrade aromatic pollutants.
Simplify the genome by deleting non-essential genes to create a predictable, low-burden host for synthetic circuits.
Common questions about our multi-gene knockout service for Pseudomonas putida.
We routinely handle KT2440, DOT-T1E, and other common laboratory strains. Customer-provided isolates can also be used if they are compatible with our transformation protocols. We recommend a pre-project feasibility assessment for non-standard strains.
Our standard multiplexing capacity is up to five genes per round. For larger edits, we can design sequential knockout campaigns or use advanced methods like recombineering. The feasibility and timeline are evaluated during the project scoping phase.
Every knockout is verified by PCR targeting the edited region plus flanking sequences, followed by Sanger sequencing to confirm the precise deletion. We also check for plasmid loss and perform a growth comparison to the parental strain if requested.
Yes, we can perform markerless editing using counter-selection methods (e.g., sacB or I-SceI systems). This is a project-specific option that may require additional validation steps. We will discuss the best selection strategy based on your downstream needs.
Get a customized quote for your Multi-Gene Knockout Strain Construction Service project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.